Cite
Safety and immunogenicity of heterologous prime-boost immunisation with Plasmodium falciparum malaria candidate vaccines, ChAd63 ME-TRAP and MVA ME-TRAP, in healthy Gambian and Kenyan adults.
MLA
Ogwang, Caroline, et al. “Safety and Immunogenicity of Heterologous Prime-Boost Immunisation with Plasmodium Falciparum Malaria Candidate Vaccines, ChAd63 ME-TRAP and MVA ME-TRAP, in Healthy Gambian and Kenyan Adults.” PloS One, vol. 8, no. 3, 2013, p. e57726. EBSCOhost, https://doi.org/10.1371/journal.pone.0057726.
APA
Ogwang, C., Afolabi, M., Kimani, D., Jagne, Y. J., Sheehy, S. H., Bliss, C. M., Duncan, C. J. A., Collins, K. A., Garcia Knight, M. A., Kimani, E., Anagnostou, N. A., Berrie, E., Moyle, S., Gilbert, S. C., Spencer, A. J., Soipei, P., Mueller, J., Okebe, J., Colloca, S., … Bojang, K. (2013). Safety and immunogenicity of heterologous prime-boost immunisation with Plasmodium falciparum malaria candidate vaccines, ChAd63 ME-TRAP and MVA ME-TRAP, in healthy Gambian and Kenyan adults. PloS One, 8(3), e57726. https://doi.org/10.1371/journal.pone.0057726
Chicago
Ogwang, Caroline, Muhammed Afolabi, Domtila Kimani, Ya Jankey Jagne, Susanne H Sheehy, Carly M Bliss, Christopher J A Duncan, et al. 2013. “Safety and Immunogenicity of Heterologous Prime-Boost Immunisation with Plasmodium Falciparum Malaria Candidate Vaccines, ChAd63 ME-TRAP and MVA ME-TRAP, in Healthy Gambian and Kenyan Adults.” PloS One 8 (3): e57726. doi:10.1371/journal.pone.0057726.